Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

November 21, 2023

Primary Completion Date

August 31, 2028

Study Completion Date

April 1, 2034

Conditions
Solid Tumor Spine Metastases
Interventions
RADIATION

Radiation: image guided dose escalated SABR using a simultaneous integrated boost (SIB)

Treatment will consist of image guided dose escalated SABR using a simultaneous integrated boost (SIB) delivered in two fractions adhering to organ at risk dose-volume histogram constraints. There will be three dose levels delivered to the Planning Target Volume\_1 (PTV\_1) in each treatment arm as follows: 28 Gy (14 Gy per fraction), 30 Gy (15 Gy per fraction) and 32 Gy (16 Gy per fraction). A lower dose of 20 Gy (10 Gy per fraction) will be delivered to the PTV\_2 which will be defined according to international consensus guidelines (Cox et al., 2012). The dose to PTV\_2 will remain the same through all dose levels. All doses are prescribed to the target volume.

Trial Locations (3)

Unknown

RECRUITING

Bon Secours/UPMC, Cork

D09V2N0

RECRUITING

St Luke's Radiation Oncology Network (SLRON) at Beaumont Hospital, Dublin

D18 AK68

RECRUITING

Beacon Hospital, Dublin

All Listed Sponsors
lead

Cancer Trials Ireland

NETWORK